| Literature DB >> 28698714 |
Munjal M Acharya1, Janet E Baulch1, Theresa A Lusardi2, Barrett D Allen1, Nicole N Chmielewski1, Al Anoud D Baddour1, Charles L Limoli1, Detlev Boison2.
Abstract
[This corrects the article on p. 42 in vol. 9, PMID: 27375429.].Entities:
Keywords: adenosine; adenosine kinase; astrogliosis; cancer therapy; cognition; neuroprotection; radiation
Year: 2017 PMID: 28698714 PMCID: PMC5502282 DOI: 10.3389/fnmol.2017.00218
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Figure 2Cranial irradiation elevates adenosine kinase (ADK) immunoreactivity and astrogliosis. Immunofluorescence analysis demonstrates that at 1 month post-treatment, compared to controls (Con and Con + 5-ITU), exposure to cranial irradiation (10 Gy) leads to elevated ADK immunoreactivity (A,B; IRR group; ADK, green; DAPI nuclear counterstain, blue) that is reduced to control levels in irradiated animals treated with 5-ITU (IRR + 5-ITU). Representative confocal micrographs show the presence reactive astrocytic cell bodies (A,C; glial fibrillary acidic protein; GFAP, red) in the hippocampal dentate hilus (DH), sub-granular zone and granule cell layer (GCL) indicating astrogliosis. IRR + 5-ITU animals showed reduced ADK and GFAP immunoreactivity compared to IRR animals. Scale bar: 30 μm.